Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.
about
Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuckHepatitis B: future curative strategiesHurdles to the Development of Effective HBV Immunotherapies and HCV VaccinesEffects of dendritic cells from hepatitis B virus transgenic mice-stimulated autologous lymphocytes on hepatitis B virus replication: a study on the impact of specific sensitized effector cells on in vitro virus replicationCoadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow.Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cureTherapeutic strategies for a functional cure of chronic hepatitis B virus infection.Present and future DNA vaccines for chronic hepatitis B treatment.Research progress of therapeutic vaccines for treating chronic hepatitis B.microRNAs and Hepatitis B.Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccinationTG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model.Immunotherapy for Chronic Hepatitis B Virus Infection.Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
P2860
Q26828598-9F5D1129-13A2-4804-98BD-79DC5B362C6EQ27011623-72F821DA-EB98-4A0F-AEBD-9250D6E462DEQ33840260-5E672DF5-DE63-4BB0-92CB-2F5231E84505Q35097598-82C06A37-85CA-444D-85C9-095A6D8BFD1EQ37309281-64DA6686-E2B6-43DF-8AEF-0E616DB85E82Q38255840-B28379C8-5BCE-42EA-8963-FE55139649A5Q38289734-CDF1522B-8392-4796-9542-0AE1077B433DQ38351585-66B50ABA-D47E-4B8E-AE36-053AA4E377F9Q38553065-322AE5E6-6768-4F37-B549-36C2C62D3C94Q38636988-87CBAF0F-FB3C-4A15-AC86-ACC48A164ECBQ38790065-EB2C1603-B6E4-4DAE-803C-2B4A664918DDQ39101021-B4BBEC42-E107-4E14-8A98-3CA4E28EEFE6Q40873221-3885EF90-8EDF-4A72-B7AF-7D21D9DCBB2BQ41607528-D7CA4F50-89FA-489D-9190-76C5FE649AB1Q41646089-954B17AE-5AF7-4C21-9E24-DC8F3A529359Q47547227-93504CD5-8082-498F-946E-B56D64A2B073Q47556416-AF70809E-F250-4530-ADE6-2CD7444EB79BQ47596485-F6C9E2EC-27F4-4EDC-8294-B508398063EA
P2860
Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunological and antiviral re ...... iciently treated by analogues.
@en
Immunological and antiviral re ...... iciently treated by analogues.
@nl
type
label
Immunological and antiviral re ...... iciently treated by analogues.
@en
Immunological and antiviral re ...... iciently treated by analogues.
@nl
prefLabel
Immunological and antiviral re ...... iciently treated by analogues.
@en
Immunological and antiviral re ...... iciently treated by analogues.
@nl
P2093
P2860
P356
P1433
P1476
Immunological and antiviral re ...... ficiently treated by analogues
@en
P2093
ANRS HB02 study group
H Fontaine
J F Meritet
M Bourgine
M L Michel
P2860
P304
P356
10.1038/MT.2013.274
P577
2013-12-05T00:00:00Z